» Journals » Hum Psychopharmacol

Human Psychopharmacology

Human Psychopharmacology is a peer-reviewed journal that focuses on the study of the effects of drugs on human behavior and cognition. It covers a wide range of topics including clinical trials, neuropharmacology, psychopharmacotherapy, and the impact of substances on mental health. The journal provides valuable insights into the field of psychopharmacology, aiding researchers, clinicians, and policymakers in understanding the effects and potential applications of various drugs on human psychology.

Details
Abbr. Hum Psychopharmacol
Start 1986
End Continuing
Frequency 8 no. a year, 1998-
p-ISSN 0885-6222
e-ISSN 1099-1077
Country United Kingdom
Language English
Specialty Pharmacology
Metrics
h-index / Ranks: 3937 86
SJR / Ranks: 8329 541
CiteScore / Ranks: 7822 3.40
JIF / Ranks: 5746 1.7
Recent Articles
11.
Turker Z, Erdogan A, Cinemre B, Metin O, Kulaksizoglu B
Hum Psychopharmacol . 2024 Jul; 39(6):e2908. PMID: 39003581
Aim: To compare opioid use disorder (OUD) patients who continue to use opioids and are in remission with buprenorphine-naloxone (B/N) in terms of some parameters and to evaluate the relationship...
12.
Lim M, Loffman S, Gaus K, Slawik S, Iyyalol R, Lee J, et al.
Hum Psychopharmacol . 2024 Jul; 39(5):e2909. PMID: 38995719
Objectives: Stimuli that are separated by a short window of space or time, known as spatial and temporal binding windows (SBW/TBWs), may be perceived as separate. Widened TBWs are evidenced...
13.
Amini K, Motallebi M, Bakhtiari K, Hajmiri M, Zamanirafe M, Sharifikia M, et al.
Hum Psychopharmacol . 2024 Jun; 39(5):e2907. PMID: 38940745
Background: In this cross-sectional study, we compared fasting serum asprosin levels and metabolic parameters between patients receiving one of three atypical antipsychotics (olanzapine, risperidone, or aripiprazole) and healthy subjects. Methods:...
14.
Knebel J, Kennedy M
Hum Psychopharmacol . 2024 May; 39(5):e2900. PMID: 38733323
Introduction: Obsessive-compulsive disorder (OCD) is marked by a high rate of treatment resistance. Patients are often left trialing medications within multiple drug classes with little response, causing heterogeneity to emerge...
15.
Joseph J, Vishwanath R, Praharaj S
Hum Psychopharmacol . 2024 Apr; 39(4):e2899. PMID: 38683854
Background: Endoxifen, a protein kinase C inhibitor and selective estrogen receptor modulator, primarily used in breast cancer treatment, has recently emerged as a potential therapeutic option for managing manic episodes...
16.
Wang R, Lu J, Herbert D, Lieberman J, Meltzer H, Tiwari A, et al.
Hum Psychopharmacol . 2024 Apr; 39(4):e2898. PMID: 38676936
Objectives: The pathology of Tardive Dyskinesia (TD) has yet to be fully understood, but there have been proposed hypotheses for the cause of this condition. Our team previously reported a...
17.
Lam E, Ip B
Hum Psychopharmacol . 2024 Apr; 39(5):e2897. PMID: 38605548
Objective: To determine the occurrence of constipation in local patients on clozapine treatment, and to compare the demographical and clinical characteristics of patients on clozapine treatment with or without constipation....
18.
Nadam I, Bellamine A, Salom R, Guilera S, Inarejos-Garcia A, Pillar G
Hum Psychopharmacol . 2024 Feb; 39(4):e2895. PMID: 38367243
Objectives: "WKUP GT", a low caffeine beverage consisting of carob, Guarana, Green Tea and Elderberry extracts was studied on attention and cognitive functions post-lunch in a pilot randomized double blind...
19.
Voon F, Loffman S, Lim M, Lee J, Iyyalol R, Martin-Iverson M
Hum Psychopharmacol . 2024 Feb; 39(3):e2896. PMID: 38353526
Objective: Stimuli received beyond a very short timeframe, known as temporal binding windows (TBWs), are perceived as separate events. In previous audio-visual multisensory integration (McGurk effect) studies, widening of TBWs...
20.
Conti D, Girone N, Boscacci M, Casati L, Cassina N, Cerolini L, et al.
Hum Psychopharmacol . 2024 Feb; 39(3):e2893. PMID: 38340275
Obsessive-compulsive disorder (OCD) is a chronic disease with a prevalence in the general population of around 2%-3%, generally accompanied by a severe impairment of functioning and quality of life. A...